The most recent “Clinical practice recommendations for managing type 2 diabetes in primary care guidelines” from the International Diabetes Federation (IDF) seeks to summarise current evidence around optimal management of people with type 2 diabetes.
IDF Clinical practice recommendations for type 2 diabetes in primary care
International Diabetes Federation (IDF), 2017
The most recent “Clinical practice recommendations for managing type 2 diabetes in primary care guidelines” from the International Diabetes Federation (IDF) seeks to summarise current evidence around optimal management of people with type 2 diabetes. The publication is intended to be a decision support tool for general practitioners, hospital-based clinicians and other primary healthcare clinicians working in diabetes. The IDF recommends that clinicians from all over the world use the guidelines for optimal management of type 2 diabetes in their clinical settings.
Relevant to the myPOC audience, the guidelines recommend screening people with risk factors for diabetes, such as age above 40 to 45 years, obesity, increased waist circumference, hypertension and family history of diabetes, and urge use of HbA1c as the diagnostic test, since it will also be necessary to decide treatment and monitor its effectiveness.
The guideline also goes onto recommend glucose monitoring for diabetes patients using insulin, during treatment adjustment, acute illness or as an education tool for self-care.
Additional tests are recommended, for example, the guideline flags that low-density lipoprotein (LDL) cholesterol should be monitored in case of risk for cardiovascular disease and screening for diabetic nephropathy is recommended via an albumin creatinine ratio (ACR) test every year.
The full guidelines can be accessed here.
The American Diabetes Association standards of care - 2023 guidelines provide recommendations for healthcare providers regarding cardiovascular disease (CVD) and risk management in people with diabetes. The authors highlight that atherosclerotic cardiovascular disease (ASCVD) and heart failure (HF) are leading causes of morbidity and mortality for people with diabetes, noting that simultaneously addressing cardiovascular (CV) risk factors can con...
American Diabetes Association recommendations for cardiovascular disease in diabetesen今すぐアクセス
The Kidney Disease: Improving Global Outcomes (KIDGO) 2022 clinical practice guidelines are based on a systematic review of evidence and aim to assist health care professionals with their decision making for people with diabetes and chronic kidney disease (CKD). The authors highlight that by 2045, 784 million people are estimated to have diabetes globally, of whom ≥40% will develop CKD, potentially leading to kidney failure requiring dialysis or ...
KIDGO clinical practice guidelines: diabetes management in chronic kidney diseaseen今すぐアクセス
The objective of this longitudinal cohort study was to determine the prevalence of chronic kidney disease (CKD) and associated risk factors in a rural South African population. The authors note that infectious and non-communicable disease are a substantial risk for CKD in Africa, but that heterogeneity in assessment and diagnostic criteria hamper the interpretation of prevalence.
Chronic kidney disease prevalence and risks in rural South Africaen今すぐアクセス